Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,totalCurrentAssets,accountsPayable,propertyPlantEquipment,changeToNetincome,changeToLiabilities,changeToOperatingActivities,totalCashFromOperatingActivities,changeInCash,netBorrowings,totalCashFromFinancingActivities,depreciation,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,currency,priceHint,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,exchange,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,IMUN,-10743883.0,481906,148693,,790407,,790407,138726,0,-287419,-287419,,-100404,,,,0,0,287419,0,1077826,,790407,790407,371473810.0,10755794.0,-10743883.0,626010.0,11911.0,49.0,-382228045.0,10303.0,253.0,11658.0,10755794.0,3070208.0,10303.0,11658.0,2710589.0,,-1178230.0,147965.0,206756.0,1687.0,1687.0,,,,,-10744136.0,en-US,US,EQUITY,False,Delayed Quote,0.0,3.5 - 3.5,3.5,0.0,0.0,0,0,finmb_206968409,Other OTC,"Immune Therapeutics, Inc.",USD,1141,893,1.0,0.4,2.5 - 48.9,-45.4,-0.9284254,2.5,48.9,1593458400,1593458400,1593458400,0.5317533,6.582,USD,4,-22.295,3.524375,-0.024374962,-0.006916109,10.935332,-7.4353323,-0.6799366,1686671,-0.15698586,15,America/New_York,EDT,-14400000,PNK,0,False,False,3.5,1630090419,0.0,3.52,3.5,3.5,7,IMMUNE THERAPEUTICS INC FLA,us_market,PRE,0.96,,,48.9,2.5,3.5244,10.9353,1.14k,893,481.91k,,393.25k,17.25%,0.00%,,,,,,,,,,,0.00%,,,1:1000,"May 05, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,"-5,181.58%",,,,,,-778.5k,3.17M,6.5820,,11.66k,0.02,3.07M,,0.00,-22.30,-191.5k,-1.86M,Value,32792,Healthcare,"Immune Therapeutics, Inc. focuses on the development, approval, and commercialization of pharmaceutical products. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. was incorporated in 1993 and is headquartered in Orlando, Florida.",Winter Park,888 613 8802,FL,1609372800,United States,http://www.immunetherapeutics.com,86400,2431 Aloma Avenue,Biotechnology,Suite 124
t-1,IMUN,-11666981.0,481906,98693,,-909382,,-909382,243836,0,-342689,-342689,,-166101,,,,0,0,342689,0,-566693,,-909382,-909382,371341120.0,11677152.0,-11666981.0,1470614.0,10171.0,48.0,-383018452.0,10303.0,200.0,9971.0,11677152.0,2844851.0,10303.0,9971.0,2562515.0,,400590.0,-87649.0,469139.0,-29966.0,-20966.0,-188000.0,9000.0,161.0,197000.0,-11667181.0,en-US,US,EQUITY,False,Delayed Quote,0.0,3.5 - 3.5,3.5,0.0,0.0,0,0,finmb_206968409,Other OTC,"Immune Therapeutics, Inc.",USD,1141,893,1.0,0.4,2.5 - 48.9,-45.4,-0.9284254,2.5,48.9,1593458400,1593458400,1593458400,0.5317533,6.582,USD,4,-22.295,3.524375,-0.024374962,-0.006916109,10.935332,-7.4353323,-0.6799366,1686671,-0.15698586,15,America/New_York,EDT,-14400000,PNK,0,False,False,3.5,1630090419,0.0,3.52,3.5,3.5,7,IMMUNE THERAPEUTICS INC FLA,us_market,PRE,0.96,,,48.9,2.5,3.5244,10.9353,1.14k,893,481.91k,,393.25k,17.25%,0.00%,,,,,,,,,,,0.00%,,,1:1000,"May 05, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,"-5,181.58%",,,,,,-778.5k,3.17M,6.5820,,11.66k,0.02,3.07M,,0.00,-22.30,-191.5k,-1.86M,Value,32792,Healthcare,"Immune Therapeutics, Inc. focuses on the development, approval, and commercialization of pharmaceutical products. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. was incorporated in 1993 and is headquartered in Orlando, Florida.",Winter Park,888 613 8802,FL,1609372800,United States,http://www.immunetherapeutics.com,86400,2431 Aloma Avenue,Biotechnology,Suite 124
t-2,IMUN,-11190622.0,481906,98693,,4094415,,4094415,130873,0,-131033,-131033,,-100681,,,,0,0,131033,0,4225448,,4094415,4094415,370908099.0,11221972.0,-11190622.0,1219462.0,31350.0,46.0,-382109070.0,10303.0,200.0,30937.0,11221972.0,2891676.0,10303.0,30937.0,2813056.0,213.0,-4326127.0,65994.0,58255.0,-67330.0,-14330.0,250000.0,53000.0,159.0,-197000.0,-11191035.0,en-US,US,EQUITY,False,Delayed Quote,0.0,3.5 - 3.5,3.5,0.0,0.0,0,0,finmb_206968409,Other OTC,"Immune Therapeutics, Inc.",USD,1141,893,1.0,0.4,2.5 - 48.9,-45.4,-0.9284254,2.5,48.9,1593458400,1593458400,1593458400,0.5317533,6.582,USD,4,-22.295,3.524375,-0.024374962,-0.006916109,10.935332,-7.4353323,-0.6799366,1686671,-0.15698586,15,America/New_York,EDT,-14400000,PNK,0,False,False,3.5,1630090419,0.0,3.52,3.5,3.5,7,IMMUNE THERAPEUTICS INC FLA,us_market,PRE,0.96,,,48.9,2.5,3.5244,10.9353,1.14k,893,481.91k,,393.25k,17.25%,0.00%,,,,,,,,,,,0.00%,,,1:1000,"May 05, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,"-5,181.58%",,,,,,-778.5k,3.17M,6.5820,,11.66k,0.02,3.07M,,0.00,-22.30,-191.5k,-1.86M,Value,32792,Healthcare,"Immune Therapeutics, Inc. focuses on the development, approval, and commercialization of pharmaceutical products. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. was incorporated in 1993 and is headquartered in Orlando, Florida.",Winter Park,888 613 8802,FL,1609372800,United States,http://www.immunetherapeutics.com,86400,2431 Aloma Avenue,Biotechnology,Suite 124
t-3,IMUN,-15285041.0,481906,-3944,,-803546,,-803546,21790,0,-18006,-18006,,-126964,,,,0,0,18006,0,-785540,,-803546,-803546,370908099.0,15330881.0,-15285041.0,2145313.0,45840.0,46.0,-386203489.0,10303.0,200.0,45267.0,15330881.0,5580439.0,10303.0,45267.0,2776837.0,373.0,658576.0,23597.0,263.0,-95886.0,39114.0,135000.0,135000.0,160.0,-197000.0,-15285614.0,en-US,US,EQUITY,False,Delayed Quote,0.0,3.5 - 3.5,3.5,0.0,0.0,0,0,finmb_206968409,Other OTC,"Immune Therapeutics, Inc.",USD,1141,893,1.0,0.4,2.5 - 48.9,-45.4,-0.9284254,2.5,48.9,1593458400,1593458400,1593458400,0.5317533,6.582,USD,4,-22.295,3.524375,-0.024374962,-0.006916109,10.935332,-7.4353323,-0.6799366,1686671,-0.15698586,15,America/New_York,EDT,-14400000,PNK,0,False,False,3.5,1630090419,0.0,3.52,3.5,3.5,7,IMMUNE THERAPEUTICS INC FLA,us_market,PRE,0.96,,,48.9,2.5,3.5244,10.9353,1.14k,893,481.91k,,393.25k,17.25%,0.00%,,,,,,,,,,,0.00%,,,1:1000,"May 05, 2021","Dec 30, 2020","Mar 30, 2021",0.00%,0.00%,"-5,181.58%",,,,,,-778.5k,3.17M,6.5820,,11.66k,0.02,3.07M,,0.00,-22.30,-191.5k,-1.86M,Value,32792,Healthcare,"Immune Therapeutics, Inc. focuses on the development, approval, and commercialization of pharmaceutical products. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. was incorporated in 1993 and is headquartered in Orlando, Florida.",Winter Park,888 613 8802,FL,1609372800,United States,http://www.immunetherapeutics.com,86400,2431 Aloma Avenue,Biotechnology,Suite 124
